Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer
British journal of surgery2005Vol. 92(5), pp. 615–623
Citations Over TimeTop 10% of 2005 papers
V.E.P.P. Lemmens, M.L.G. Janssen‐Heijnen, C D G W Verheij, Saskia Houterman, O.J. Repelaer van Driel, J.W.W. Coebergh
Abstract
Elderly patients with co-morbidity were treated less aggressively and had a worse survival than those with no concomitant disease.
Related Papers
- → Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery(2020)40 cited
- → The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis(2021)19 cited
- → Clinical characteristics of synchronous colorectal cancer are different according to tumour location(2006)27 cited
- → Safety of diuretic administration during the early management of dyspnea patients who are not finally diagnosed with acute heart failure(2020)3 cited
- → Table S1-S4 from Metabolic Phenotype and Risk of Colorectal Cancer in Normal-Weight Postmenopausal Women(2023)